Healthcare provider profile · identity verified

Richard Holmes, MD

Internal Medicine · BROOKLYN, NY · NPI 1225121452

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	751	282
Amlodipine Besylate	Amlodipine Besylate	578	213
Metoprolol Succinate	Metoprolol Succinate	328	120
Metformin Hcl	Metformin Hcl	306	112
Losartan Potassium	Losartan Potassium	305	107
Albuterol Sulfate Hfa	Albuterol Sulfate	254	67
Diclofenac Sodium	Diclofenac Sodium	247	113
Rosuvastatin Calcium	Rosuvastatin Calcium	238	74
Metformin Hcl Er	Metformin Hcl	202	78
Jardiance	Empagliflozin	184	42
Nifedipine Er	Nifedipine	182	63
Hydrochlorothiazide	Hydrochlorothiazide	180	62
Irbesartan	Irbesartan	180	58
Lisinopril	Lisinopril	157	50
Simvastatin	Simvastatin	148	55
Januvia	Sitagliptin Phosphate	139	39
Donepezil Hcl	Donepezil Hcl	127	45
Gabapentin	Gabapentin	126	60
Levothyroxine Sodium	Levothyroxine Sodium	121	38
Ozempic	Semaglutide	116	20
Furosemide	Furosemide	115	51
Meloxicam	Meloxicam	115	39
Omeprazole	Omeprazole	111	50
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	104	35
Tamsulosin Hcl	Tamsulosin Hcl	98	37
Glimepiride	Glimepiride	92	29
Chlorthalidone	Chlorthalidone	91	36
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	90	32
Fluticasone Propionate	Fluticasone Propionate	89	37
Allopurinol	Allopurinol	88	29
Carvedilol	Carvedilol	87	33
Trazodone Hcl	Trazodone Hcl	84	30
Alendronate Sodium	Alendronate Sodium	82	24
Montelukast Sodium	Montelukast Sodium	79	27
Clopidogrel	Clopidogrel Bisulfate	78	23
Farxiga	Dapagliflozin Propanediol	71	19
Glipizide Er	Glipizide	65	19
Enalapril Maleate	Enalapril Maleate	60	21
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	58	29
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	57	17
Metoprolol Tartrate	Metoprolol Tartrate	57	22
Pioglitazone Hcl	Pioglitazone Hcl	56	17
Pravastatin Sodium	Pravastatin Sodium	56	21
Atenolol	Atenolol	55	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	53	21
Lidocaine-Prilocaine	Lidocaine/Prilocaine	51	20
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	50	15
Alcohol Prep Pads	Alcohol Antiseptic Pads	49	18
Single Use Swab	Alcohol Antiseptic Pads	49	24
Ammonium Lactate	Ammonium Lactate	48	23
Ezetimibe	Ezetimibe	47	18
Triamcinolone Acetonide	Triamcinolone Acetonide	41	23
Eliquis	Apixaban	40	18
Hydralazine Hcl	Hydralazine Hcl	40	15
Pantoprazole Sodium	Pantoprazole Sodium	40	14
Cilostazol	Cilostazol	39	15
Novolog Flexpen	Insulin Aspart	39	14
Famotidine	Famotidine	36	suppressed
Spironolactone	Spironolactone	36	13
Entresto	Sacubitril/Valsartan	32	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	31	16
Bupropion Hcl Sr	Bupropion Hcl	31	21
Memantine Hcl	Memantine Hcl	31	suppressed
Labetalol Hcl	Labetalol Hcl	30	11
Meclizine Hcl	Meclizine Hcl	30	17
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	29	14
Colchicine	Colchicine	27	11
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	27	27
Hydrocortisone	Hydrocortisone	27	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	12
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	27	suppressed
Glipizide	Glipizide	26	suppressed
Valsartan	Valsartan	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	15
Tizanidine Hcl	Tizanidine Hcl	25	17
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	24	suppressed
Baclofen	Baclofen	23	13
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	21
Warfarin Sodium	Warfarin Sodium	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	11
Janumet Xr	Sitagliptin Phos/Metformin Hcl	22	suppressed
Repaglinide	Repaglinide	22	11
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Finasteride	Finasteride	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Rybelsus	Semaglutide	19	suppressed
Cephalexin	Cephalexin	18	16
Clonidine	Clonidine	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Nitroglycerin	Nitroglycerin	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Prednisone	Prednisone	17	16
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Sertraline Hcl	Sertraline Hcl	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Fluocinonide	Fluocinonide	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Clonazepam	Clonazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error